Fish Oil Supplements Prevent Declines in Heart Rate Variability

Fish Oil Supplements Prevent Declines in Heart Rate Variability
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. Eating More Than Five Portions Of Fruit And Vegetables a Day Can Substantially Reduce The Risk Of Stroke UK researchers reveiwed data from eight studies involving over 257 500 people from Europe, Japan, and the USA, observing that compared to individuals who have less than three fruit and vegetable servings a day, those with three to five servings per day had an 11% reduction in the incidence of stroke, while those with more than five servings per day had a relative reduction of 26%. Eating More Than Five Portions Of Fruit And Vegetables a Day Can Substantially Reduce The Risk Of Stroke UK researchers reveiwed data from eight studies involving over 257 500 people from Europe, Japan, and the USA, observing that compared to individuals who have less than three fruit and vegetable servings a day, those with three to five servings per day had an 11% reduction in the incidence of stroke, while those with more than five servings per day had a relative reduction of 26%. Tonalin® CLA Study Among 'Most Noteworthy' in ODS Annual Bibliography Tonalin® CLA (conjugated linoleic acid) research documenting the long-term safety and efficacy of Tonalin® CLA supplementation, published in the American Journal of Clinical Nutrition (Gaullier J-M. et al., Am. J. Clin. Nutr., 2004; 79(6):1118-1125), was selected as one of 25 “exemplary” papers to appear in the National Institutes of Health (NIH) Office of Dietary Supplements’ (ODS) Annual Bibliography of Significant Advances in Dietary Supplement Research 2004. Tonalin® CLA Study Among 'Most Noteworthy' in ODS Annual Bibliography Tonalin® CLA (conjugated linoleic acid) research documenting the long-term safety and efficacy of Tonalin® CLA supplementation, published in the American Journal of Clinical Nutrition (Gaullier J-M. et al., Am. J. Clin. Nutr., 2004; 79(6):1118-1125), was selected as one of 25 “exemplary” papers to appear in the National Institutes of Health (NIH) Office of Dietary Supplements’ (ODS) Annual Bibliography of Significant Advances in Dietary Supplement Research 2004. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. New Study On Saw Palmetto Demonstrates Puzzling Results A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement. New Study On Saw Palmetto Demonstrates Puzzling Results A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. Study: Popular Herbal Therapy No Better Than Placebo New England Journal of Medicine double-blind, placebo controlled study examines saw palmetto for Benign Prostatic Hyperplasia (BPH) and finds that after one year, there was no difference in symptom changes between the group taking saw palmetto and those recieiving placebo, contradicting previous research. Study: Popular Herbal Therapy No Better Than Placebo New England Journal of Medicine double-blind, placebo controlled study examines saw palmetto for Benign Prostatic Hyperplasia (BPH) and finds that after one year, there was no difference in symptom changes between the group taking saw palmetto and those recieiving placebo, contradicting previous research. Dietary Supplement Industry Claims Saw Palmetto Study Misleading NNFA points out a number of flaws in New England Journal of Medicine (NEJM) study, specifically a substantial existing body of clinical studies, some with larger patient populations, that support the efficacy of this supplement for mild to moderate symptoms associated with benign prostatic hyperplasia (BPH). Dietary Supplement Industry Claims Saw Palmetto Study Misleading NNFA points out a number of flaws in New England Journal of Medicine (NEJM) study, specifically a substantial existing body of clinical studies, some with larger patient populations, that support the efficacy of this supplement for mild to moderate symptoms associated with benign prostatic hyperplasia (BPH). New Saw Palmetto Study Fails to Corroborate Earlier Research AHPA suggests that new study needs to be considered in the totality of clinical research on saw palmetto, including 2002 meta-analysis of 21 previous studies; notes no difference in risk of serious adverse events in current study. New Saw Palmetto Study Fails to Corroborate Earlier Research AHPA suggests that new study needs to be considered in the totality of clinical research on saw palmetto, including 2002 meta-analysis of 21 previous studies; notes no difference in risk of serious adverse events in current study. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	According to an article on News-medical.net, citing a randomized controlled study published in the December 2005 American Journal of Respiratory and Critical Care Medicine, a two-gram fish oil supplement given daily to 26 elderly persons prevented a decline in heart rate variability associated with same-day exposure to indoor particulate matter, compared to the control group given soy oil supplements. Article on News-medical.net
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software